
Ardigen is a leading AI-powered Contract Research Organization (CRO) specializing in drug discovery and clinical development. Founded in 2015, Ardigen leverages advanced artificial intelligence, machine learning, and bioinformatics to transform biomedical data into actionable insights, accelerating drug discovery and increasing the probability of clinical success. The company offers end-to-end AI-driven solutions including target identification, biologics and small molecule discovery, phenotypic profiling, clinical trial optimization, and data management. Ardigen's proprietary platforms such as the Ardigen biologics discovery platform and phenAID phenotypic profiling platform integrate in silico modeling with wet-lab validation to optimize drug candidates efficiently. With over 520 projects completed and trusted by more than 100 clients including top pharmaceutical companies, Ardigen combines multidisciplinary expertise in molecular biology, data science, and software engineering to deliver customized AI solutions that reduce timelines and costs in drug development.

Ardigen is a leading AI-powered Contract Research Organization (CRO) specializing in drug discovery and clinical development. Founded in 2015, Ardigen leverages advanced artificial intelligence, machine learning, and bioinformatics to transform biomedical data into actionable insights, accelerating drug discovery and increasing the probability of clinical success. The company offers end-to-end AI-driven solutions including target identification, biologics and small molecule discovery, phenotypic profiling, clinical trial optimization, and data management. Ardigen's proprietary platforms such as the Ardigen biologics discovery platform and phenAID phenotypic profiling platform integrate in silico modeling with wet-lab validation to optimize drug candidates efficiently. With over 520 projects completed and trusted by more than 100 clients including top pharmaceutical companies, Ardigen combines multidisciplinary expertise in molecular biology, data science, and software engineering to deliver customized AI solutions that reduce timelines and costs in drug development.